BNET Industries

Market Cap:$3.9B
Last Fiscal Year Sales:$1.5B
  • Public
  • US
Dow Jones Description

Millipore (NYSE: MIL) is a Life Science leader providing cutting-edge technologies, tools and services for bioscience research and biopharmaceutical manufacturing. Since its founding in 1954, Millipore has expanded its capabilities through strategic acquisitions, targeted capital investments, and organic growth.

CEOMartin Madaus
Number of Employees 5,900
Contact Information

80 Ashby Rd

Bedford, Massachusetts 01730-2237

millipore.com

(781) 533-6000

NAICS Code Analytical Laboratory Instrument Manufacturing: 334516

Recent Events

  • Millipore Unveils Its First Single-Use Bioreactor For Process Development

    6/12/09 - Product Announcement - View Story

  • Millipore Unveils Its First Single-Use Bioreactor For Process Development

    6/16/09 - Product Announcement - View Story

  • Millipore Corp. Appoints New VP, Strategy and Corporate Development

    6/15/09 - Mgmt. Change Entering - Business Development - View Story

  • Company and People Notes: Dr. Reddy and GSK Form Pact; Hollis-Eden Appoints CEO; More...

    6/17/09 - Site Opening - View Story

  • Cell-Based Assay

    6/07/09 - Product Announcement - View Story

  • BUYINS.NET: Market Maker Surveillance Report. Top 6 Abnormal Price Friction Stocks For May 22, 2009

    5/26/09 - Joint Venture / Alliance - View Story

  • TSC Ratings' Changes: Hansen Natural

    5/12/09 - Bond / Stock Rating - View Story

  • Millipore Reports 1Q Financial Results and Raises Outlook for 2009

    5/18/09 - Financial Announcement - View Story

  • Millipore And Microbix Form Strategic Partnership To Develop Novel Purification Process In Vaccine Manufacturing

    4/28/09 - Licensing / Contract - View Story

  • Millipore and Microbix Form Strategic Partnership to Develop Novel Purification Process in Vaccine Manufacturing

    4/23/09 - Licensing / Contract - View Story

  • Millipore Corporation MIL and Novozymes, Inc. (NZYMb.CO) Launch Innovative CellPrimeTM Product for Large Scale Industrial...

    4/07/09 - Product Announcement - View Story

  • Millipore outfits new UML lab: Billerica company donates $225G worth of gear for bioscience facility

    4/14/09 - Financial Announcement - View Story

  • Millipore Unveils Industry's Most Integrated Single-Use Manufacturing Solutions at INTERPHEX 2009

    3/17/09 - Product Announcement - View Story

  • Millipore Corporation MIL And CXR Biosciences Introduce Toxicity Reporter Assay Panel

    3/13/09 - Product Announcement - View Story

  • Millipore Buys Assay Technology

    2/26/09 - Merger / Acquisition - View Story

  • Millipore: Cost Cutting Proves Prescient For This Maker Of Medical Products

    2/24/09 - Merger / Acquisition - View Story

News & Analysis

millipore corp. - All News and Analysis

Decision Makers

Name (plus bio) Position
Martin Madaus CEO
Dominique Baly President, Bioscience Division
Jean-Paul Mangeolle President, Bioprocess Division
Jonathan DiVincenzo President of Millipore's Bioscience Division
Anthony L. Mattacchione Cao
Charles Wagner Vice President and Chief Financial Officer
Dennis W. Harris Corporate Vice President, Chief Scientific Officer
Kathleen Allen Chief Financial Officer
Andrew Bulpin Vice President of Millipore's Upstream Bioprocessing Business Unit
Bruce J. Bonnevier Global Vice President of Human Resources
Geoffrey Crouse Vice President, Life Science Business Unit
Geoffrey Ide Corporate Vice President, International Markets
Gregory Sam Vice President of Corporate
Jeffrey Rudin Corporate Vice President
John Lary Vice President
Kathleen Stearns Vice President
Kevin Sanborn Vice President, Business Development and Strategic Planning
Lynn Garvin Vice President, Corporate Communications
Paul Chapman Vice President, Downstream Processing
Peter Kershaw Corporate Vice President, Worldwide Manufacturing Operations
Rick Ryan Vice President of Millipore's Drug Discovery and Development Business Unit
Roland Heinrich Vice President, Res & Development, Bioprocess Division
Thomas Anderson Vice President, Corp Communications
Vinay Goel President, Membrane Technology Division & Vice President
Wei Zhang Vice President
Bob Levenson Director of Global Talent Development
Karen Hall Director of Corporate Communications
Melvin D. Booth Lead Director
Anthony Wilkins Manager, Business Development
Danielle Aridis-Lang Sales Manager
Debbie Stanley Marketing Manager
Debra Macivor Product Manager for Biomarkers and Immunoassays
Fabien Carrero Manager, Business Development, OEM Products
Greg Hoff Marketing Communications Manager, Millipore Corporation
Gregory Arns Account Manager, Bioscience, Life Science Products
Jean Wong Account Manager, Qa Products
Karen Gobler Manager, Corp Communications
Kenneth W. Ludwig Product Manager
Lori McGolrick Account Manager, Bioscience, Life Science Products
Marshall Martin Marketing Manager
Matthew G Brown Bioscience Licensing Manager
Michael Grzonka Manager, Development
Morgan Norris Product Marketing Manager
Sandrine Mercier Product Manager
Tom Coyle Business Development Manager, Product
Devin Jennings Manufacturing Scientist
Dianna Otto Technology Transfer Administrative Coordinator
Geoffrey Helliwell Treasurer
Jill Lundy Application Specialist, Bioprocess Division
Mark Hoffman Consultant
Phil Theodore Corporate Secretary
Tara Duplaga Corporate Giving and Community Affairs Representative
Daniel Bellus Director
Edward M. Scolnick Director
Karen E. Welke Director
Robert C. Bishop Director
Steven A Kates Director

Board of Directors

Name (plus bio) Position
John F. Reno Chairman of the Committee
Maureen A. Hendricks Chair
Donald B. Melson Board of Directors
Joshua S Young Board of Directors
Richard J. Lane Board of Directors
Rolf A. Classon Board of Directors
Roy Millender Board of Directors
Organization Position Status
Predictive Biosciences, Inc. Millipore CEO and Chairman Current
Millipore Corporation CEO Current
Millipore Corporation President Current
Massachusetts High Technology Council, Inc Director Current
National Council YMCA of the USA Director Current
New England Health Care Board Member Current
Roche Diagnostics Corporation Chief Executive Officer Former
Roche Diagnostics Corporation President Former
Roche Molecular Systems, Inc. Vice President of Business Development Former
Boehringer Mannheim Former
Roche Former
Millipore Corporation Chairman Current
Millipore Corporation Director Former
Predictive Biosciences, Inc. Board Member Current
Organization Position Status
Millipore Corporation President, Bioscience Division Current
Millipore Intertech President Former
Millipore Corporation Vice President Former
Organization Position Status
Millipore Corporation President, Bioprocess Division Current
Millipore Corporation Vice President Current
Mykrolis Corporation Vice President of Operations Former

Array

Organization Position Status
Millipore Corporation President of Millipore's Bioscience Division Current
Organization Position Status
Millipore Corporation Cao Current
Millipore Corporation Vice President Current
Millipore Corporation Corporate Controller Current
Organization Position Status
Millipore Corporation Vice President and Chief Financial Officer Current
Millipore Corporation Manager Former
Cooper's Inc. Manager Former
Boston College Master In Business Administration Former
Boston College B.S. Former
Organization Position Status
Seracare Diagnostics & Seracare Bioprocessing Chief Scientific Officer Current
Millipore Corporation Corporate Vice President, Chief Scientific Officer Current
Microchip Biotechnologies, Inc. Founder and Secretary Current
Microchip Biotechnologies Inc. Founder of Mbi Current
Microchip Biotechnologies, Inc. Board of Directors Current
Microchip Biotechnologies Inc. Secretary Current
Serologicals Corporation Development, Business Development and Chief Scientific Officer Former
Serologicals Corporation Vice President, Research Former
Aclara Biosciences, Inc. Senior Research& Development and Business Positions Former
University of Sussex Ph.D Degrees Former
University of Sussex B.Sc. Former
University of Sussex Degree Former
Organization Position Status
Millipore Corporation Chief Financial Officer Current
Millipore Corporation Board of Directors Current
Millipore Corporation Corporate Vice President Former
Millipore Corporation Corporate Controller Former
Arthur Young, Inc. Public Accounting Former
Organization Position Status
Millipore Corporation Vice President of Millipore's Upstream Bioprocessing Business Unit Current

Dr. Bruce Bonnevier joined Millipore Corporation as Global Vice President of Human Resources in January 2006. Prior to joining Millipore, Dr. Bonnevier served as Vice President of Human Resources for Hillenbrand Industries and Shipley Company, and held a variety of Human Resources as well as Quality Management positions with Rohm and Haas, Michelin Tire Corporation, Union Carbide Corporation and Reynolds Metals Company. Dr. Bonnevier holds a Ph.D. in Human and Organizational Systems from The Fielding Institute, M.S. in Dynamics of Organization from University of Pennsylvania, M.A. in Statistics and Operations Research from Pennsylvania State University, and a B.S. in Mathematics and Statistics from Pennsylvania State University.

Organization Position Status
Millipore Corporation Global Vice President of Human Resources Current
Shipley, Inc. Vice President of Human Resources Former
Reynolds Metals, Inc. Former
Union Carbide Corporation Former
Fielding Institute Ph.D. In Human and Organizational Systems Former
The Pennsylvania State University M.A. In Statistics and Operations Research Former
The Pennsylvania State University B.S. In Mathematics and Statistics Former
Organization Position Status
Millipore Corporation Vice President, Life Science Business Unit Current
Organization Position Status
Millipore Corporation Corporate Vice President, International Markets Current
New Hampshire College Masters of Business Administration Former
Saint Anselm College B.A. In Natural Sciences Former

Array

Organization Position Status
Millipore Corporation Vice President of Corporate Current
Watson Pharmaceuticals, Inc. Senior Director, Corporate Qaâ??Quality Management Former
National Foundation Research Scientist Former
The Pennsylvania State University B.S. Degree In Biology Former
Organization Position Status
Millipore Corporation Corporate Vice President Current
Cpg Corporate Vice President, General Counsel, Secretary Current
Esgro and Lif Resource Center Corporate Vice President, General Counsel, Secretary Current
Millipore Corporation Secretary Current
Millipore Corporation General Counsel Former
Rutgers School of Law J.D. Former
Rutgers College Former
Organization Position Status
Millipore Corporation Vice President Current
Organization Position Status
Millipore Corporation Vice President Current
Organization Position Status
Millipore Corporation Vice President, Business Development and Strategic Planning Current
Organization Position Status
Millipore Corporation Vice President, Corporate Communications Current
Organization Position Status
Millipore Corporation Vice President, Downstream Processing Current
Organization Position Status
Millipore Corporation Corporate Vice President, Worldwide Manufacturing Operations Current
Hologic, Inc. Corporate Vice President Former
Hologic, Inc. General Manager, Lorad Division Former
Johnson & Johnson Former
C.R. Bard, Inc. Former
Bespak Plc Former
Duquesne University Master In Business Administration Former
Elizabethtown College B.A. Former
Duquesne University Degree Former
Organization Position Status
Millipore Corporation Vice President of Millipore's Drug Discovery and Development Business Unit Current
Organization Position Status
Millipore Membrane Technology Division President Current
Millipore Corporation Vice President, Res & Development, Bioprocess Division Current
Organization Position Status
Millipore Corporation Vice President, Corp Communications Current
French American Chamber of Commerce, New England Board of Directors Current
Boston College M.A. In English Literature Former
College of the Holy Cross B.A. In Chemistry Former
Organization Position Status
Millipore Corporation President, Membrane Technology Division & Vice President Current
Millipore Membrane Technology Division President Former
Organization Position Status
Millipore Corporation Vice President Current

Robert M. Levenson, Esq. is a Maryland attorney involved in real estate and financial transactions for almost 20 years. Mr. Levenson currently serves as a Vice President with LandAmerica 1031 Exchange Company, a division of a Fortune 1000 company focused on tax-deferred exchanges for business and investment clients. In his career, Mr. Levenson has participated in more than 180 real estate transactions valued at over $140 million. His experience includes working as a real estate broker, a lender, a broker of existing mortgages on the secondary market, a principal/small developer, a property manager, and performing document review as part of a legal team on a large acquisition for a NYSE-listed REIT. Mr. Levenson also has experience working for Aspen Systems and the U.S. Department of Housing and Urban Development.

Organization Position Status
The Company Exchange Limited Vice President Current
Millipore Corporation Director of Global Talent Development Current
Solution Works, LLC Maryland Attorney Current
Exchange Services Inc. Principal Current
Hopkinton Current
Blackacre 1031 Exchange Services LLC Managing Member Current
Lockheed Martin Aspen Systems Former
American University J.D. Former
Boston College MBA Former
Boston University BA In Political Science Former
Organization Position Status
Millipore Corporation Director of Corporate Communications Current
Millipore Corporation Board of Directors Current
Organization Position Status
Millipore Corporation Lead Director Current
Technotv.Net Current
PRA International Inc. Chairman of the Boards Current
Genstar Capital LLC Board of Directors Current
Focus Diagnostics, Inc. Board of Directors Current
Millipore Corporation Board of Directors Current
Novascreen Biosciences Corporation Board Member Current
Cromedica Director Current
Ventria Bioscience Board Member Current
MedImmune, Inc. Board of Directors Current
Syntex Laboratories President Former
Human Genome Sciences, Inc. President Former
Human Genome Sciences, Inc. Chief Operating Officer Former
Syntex Corporation Vice President Former
Prestwick Pharmaceuticals, Inc Chairman Former
Prestwick Pharmaceuticals, Inc Director Former
PRA International Inc. Board of Directors Former
Northwest Missouri State University Undergraduate Degree Former
Organization Position Status
Millipore Corporation Manager, Business Development Current
Organization Position Status
Millipore Corporation Sales Manager Current
Organization Position Status
Millipore Corporation Marketing Manager Current
Organization Position Status
Millipore Corporation Product Manager for Biomarkers and Immunoassays Current
Organization Position Status
Millipore Corporation Manager, Business Development, OEM Products Current
Organization Position Status
Millipore Corporation Marketing Communications Manager, Millipore Corporation Current
Organization Position Status
Millipore Corporation Account Manager, Bioscience, Life Science Products Current
Organization Position Status
Millipore Corporation Account Manager, Qa Products Current
Organization Position Status
Millipore Corporation Manager, Corp Communications Current
Millipore Corporation-Pharmaceuticals Division Pr Manager Former
Organization Position Status
Millipore Corporation Product Manager Current
Organization Position Status
Millipore Corporation Account Manager, Bioscience, Life Science Products Current
Organization Position Status
Millipore Corporation Marketing Manager Current
Organization Position Status
Millipore Corporation Bioscience Licensing Manager Current
Organization Position Status
Millipore Corporation Manager, Development Current
Organization Position Status
Millipore Corporation Product Marketing Manager Current
Organization Position Status
Millipore Corporation Product Manager Current
Organization Position Status
Millipore Corporation Business Development Manager, Product Current

Devin has a special interest in spinal cord injury, because his brother-in-law is a C-4/5 quadriplegic. He earned his Bachelor's degree in Biological Sciences with an emphasis in Neurology, Physiology & Behavior from the University of California, Davis, and he currently works as a Manufacturing Scientist at Millipore. He enjoys spending time with his family, painting, and playing basketball.

Organization Position Status
Millipore Corporation Manufacturing Scientist Current
Quad Foundation, Inc. Secretary Current
University of California, Davis Bachelor's Degree In Biological Sciences Former
Organization Position Status
Millipore Corporation Technology Transfer Administrative Coordinator Current
Organization Position Status
Millipore Corporation Treasurer Current
Millipore Corporation Treasurer Current
Organization Position Status
Millipore Corporation Application Specialist, Bioprocess Division Current

Mr. Hoffman has been a Director of Millipore since 1976 and is currently a Member of the Audit and Finance Committee and the Management Development and Compensation Committee. Mr. Hoffman received an undergraduate degree from Harvard College in Engineering and Applied Physics, a Masters degree in economics from Cambridge University and an M.B.A. from the Harvard Graduate School of Business Administration. In 1963, as an M.I.T. Fellow in Africa, Mr. Hoffman joined the East African Common Services Organization as Acting Financial Secretary. In 1966, Mr. Hoffman joined the International Finance Corporation (investment banking affiliate of the World Bank) as Investment Officer responsible for private sector financing in Europe and Mexico. From 1969 to 1974, Mr. Hoffman served as a Director of Hambros Bank, Ltd., London, England and Head of its International Banking and Issues Division. From 1975 to 1981, Mr. Hoffman was a Director, Senior Vice President and Chief Financial Officer of George Weston, Ltd. and was appointed President of its Resource Group in 1981. From 1982 until 1984, Mr. Hoffman served as Managing Director of Guinness Peat Group p.l.c., engaged through subsidiaries worldwide in merchant banking, insurance brokerage, leasing, property, energy and other management and financial service activities. Since 1984, when he undertook his current activities as an independent investor and consultant, Mr. Hoffman has served as an independent

Organization Position Status
Millipore Corporation Consultant Current
Hermes Focus Asset Management Limited Director Current
George Weston Limited Director Current
Millipore Corporation Director Current
George Weston Limited Chief Financial Officer Former
George Weston Limited Senior Vice President Former
Guinness Peat Group plc Managing Director Former
International Finance Corporation Former
Cambridge University Masters Degree In Economics Former
Harvard College Undergraduate Degree Former

Phil Theodore was named Senior Vice President and General Counsel of John H. Harland Company in 2006. He replaces John Walters who will retire in early 2007. He is responsible for all of Harland's legal and corporate governance activities. Theodore brings almost 30 years of legal experience to Harland, most recently as Vice President, General Counsel and Corporate Secretary for Serologicals Corporation prior to its acquisition by Millipore Corporation earlier this year. He joined Serologicals in 2004 after a 22-year career with King & Spalding LLP, where he specialized in mergers, acquisitions, corporate governance and corporate finance. Theodore received his bachelor's degree from the University of Tennessee and his law degree from the University of Cincinnati.

Organization Position Status
Harland Financial Solutions, Inc. Senior Vice President and General Counsel Current
Serologicals Corporation Corporate Secretary Current
Millipore Corporation Corporate Secretary Current
John H. Harland Company Senior Vice President and General Counsel Former
Serologicals Corporation Vice President, General Counsel Former
King & Spalding LLP Former
University of Cincinnati Law Degree Former
The University of Tennessee Bachelor's Degree Former
Organization Position Status
Millipore Corporation Corporate Giving and Community Affairs Representative Current
Organization Position Status
Better Chance Inc Founder Current
Millipore Corporation Chairman of the Committee Current
Nelson Irrigation Corporation Director Current
Dynatech LLC Chief Executive Officer Former
Dynatech LLC President Former
Dynatech LLC General Manager Former
Millipore Corporation Director Current
Northwestern University M.B.A. Former
Dartmouth College Undergraduate Degree Former

Maureen A. Hendricks has been a director of our company since its inception in June 2006 and is the chairperson of our audit committee and a member of the compensation and governance committees. On her retirement in 2001, Mrs. Hendricks was the head of global energy and power at Salomon Smith Barney, where she also acted as a senior advisory director until 2003, at which time she retired, although she continued to serve as a director of certain companies, including Millipore Corporation, as described below. Mrs. Hendricks started her career at J.P. Morgan & Co. where she served as the head of global debt capital markets, the head of North American fixed income, the head of European equities, and the co-head of global equity derivatives. Mrs. Hendricks has been a member of the board of directors of Millipore Corporation since 1995 and has previously served as the chair of the audit committee and the chair of the management development and compensation committee of that firm. She is currently the chair of the governance committee of Millipore.

Organization Position Status
Millipore Corporation Chair Current
Opteum Financial Services, LLC Director Current
Millipore Corporation Board of Directors Current
Salomon Brothers Inc. Managing Director Former
Salomon Smith Barney Managing Director Former
Salomon Brothers Inc. Co-Head of Global Energy Former
NTR Acquisition Company Board of Directors Current
Smith College Former

Prof. Dr. Bellus has been a Director of Millipore since 2000 and is currently a Member of the Governance and Public Policy Committee and the Technology Committee. Prof. Dr. Bellus received his Master s Degree and a Ph.D. in Chemistry from Slovak Technical University (Bratislava) in 1967. He continued his studies as a Postdoctoral Fellow at the Federal Institute of Technology (ETH) in Zurich (1967-1969). From 1969-1996, Prof. Dr. Bellus served in positions of increasing responsibility with Ciba-Geigy Ltd., a Swiss pharmaceutical company in Basel: Department Head, Central Research Laboratories (1969-1981); Director, Central Research Laboratories, responsible for development of several emerging synthetic methodologies (1981-1985); Director, Research & Development, Agricultural Division of Ciba-Geigy worldwide (1985-1991), Director, Corporate Research Units, responsible for the direction of Ciba-Geigy s research programs and collaborative strategic alliances world-wide in areas of bioorganic chemistry and biomaterials (1991-1996), and a global Head of Additives Research of Ciba SC Inc., Basel (until 2001). Since 1980, he has also lectured as a Professor at the Institute of Organic Chemistry, University of Fribourg. Since 1997, he has been President and CEO of Bellus Science and Innovation, International Consulting, located in Riehen/Basel (Switzerland). Prof. Dr. Bellus has been a named inventor on 50 patents and is the author or co-author of numerous scientific papers relating to the synthesis and use of compounds for the chemical and pharmaceutical industries. He has received numerous scientific honors including Gold Medal of the Slovak Chemical Society (1993); Fellow of the Royal Society of Chemistry (U.K.) (1996); Honorary Ph.D. of Czech Technical University (Prague) (1997) and Foreign Fellow of the Japan Society for the Promotion of Science (1999). Prof. Dr. Bellus is a member of many scientific societies, including Swiss and American Chemical Society. He also serves as a member and delegate of Swiss IUPAC Committee; as a member of the Board of Governors of the Foundation for Discovery-to-Business Transfer (Basel) and as a member of several Scientific Advisory Boards in Switzerland and the Czech Republic.

Organization Position Status
Innovation Corp President Current
Millipore Corporation Director Current
Millipore Corporation Committee Member Current
Hillenbrand Industries, Inc. Chief Executive Officer Former
3M Company Vice President, Medical Markets Group Former
Salomon Smith Barney, Inc. Managing Director Former
Autoimmune, Inc. Chairman of the Board Former

Donald B. Melson joined Analogic as Vice President—Corporate Controller in March 2006. Mr. Melson was previously Vice President and Corporate Controller of Millipore Corporation, a publicly held global manufacturer of products and services for biopharmaceutical manufacturing and life science laboratories, from 2000 to 2006. Prior to this position, Mr. Melson held a number of financial management positions in Millipore Corporation and W. R. Grace & Co.

Organization Position Status
Analogic Corporation Vice President, Corporate Controller Current
Millipore Corporation Board of Directors Current
Millipore Corporation Vice President Former
Millipore Corporation Corporate Controller Former
Organization Position Status
MPM Capital Limited Partnership Executive Advisor Current
Renovis, Inc. Current
Hypnion, Inc. Current
Broad Institute Current
National Academy of Sciences Board of Directors Current
Millipore Corporation Director Current
Alinea Pharmaceuticals, Inc Board of Directors Current
Aveo Pharmaceuticals, Inc. Board of Directors Current
Vlst Corp Board of Directors Current
Alnylam Pharmaceuticals, Inc. Board of Directors Current
The Bipolar Board of Directors Current
American Academy of Arts and Sciences Member Current
National Academy of Sciences Member Current
Merck Research Labs President Former
Merck & Co. Inc. President Former
National Cancer Institute Chief of the Laboratory Former
Merck & Co. Inc. Executive Vice President for Science and Technology Former
Virus Inc. Executive Director Former
Basic Research Executive Director Former
Clarus Ventures, LLC Venture Partner Former
The Regents Lecturer Former
McLean Hospital Former
Harvard University M.D. Former
Harvard Medical School M.D. Former
Harvard College A.B.in Biochemical Sciences Former
Harvard University B.A. Former
The National Institute of Mental Health member Former
Millipore Corporation member Former
Organization Position Status
Millipore Corporation Board of Directors Current
Organization Position Status
Millipore Corporation Director Current
Project Hope Board of Directors Current
Millipore Corporation Committee Member Current
Health Care, Inc. Group Director Former
Pentair, Inc. Board of Directors Former
Wittenberg University Former
University of Wisconsin Former
Organization Position Status
Millipore Corporation Board of Directors Current
Organization Position Status
Millipore Corporation Director Current
Autoimmune, Inc. Chairman, President and Chief Executive Officer Former
American Hospital Supply Corporation Former
Allergan, Inc. Former
University of Miami M.B.A. Former
Organization Position Status
Healthcarereps.Com Current
Xanodyne Pharmaceuticals, Inc. Chairman of the Board of Directors Current
Hillenbrand Industries, Inc. Chairman Current
Auxilium Pharmaceuticals, Inc. Chairman of The Board of Directors Current
Bayer HealthCare, Animal Health Division Chairman Current
Hill-Rom Company, Inc. Chairman, Hill, Rom Holdings, Inc., Batesville, In Current
Prometheus Laboratories, Inc. Board of Directors Current
Esgro and Lif Resource Center Board of Directors Current
Eurand America, Inc. Board of Directors Current
Millipore Corporation Board of Directors Current
PharmaNet Inc. Board of Directors Current
Clinical Trials Today Director Current
ISTA Pharmaceuticals, Inc. Director Current
Enzon Pharmaceuticals, Inc. Board of Directors Current
Millipore Corporation Committee Member Current
Hillenbrand, Inc. Chief Executive Officer Former
Hillenbrand Industries, Inc. Chief Executive Officer Former
Bayer HealthCare, Animal Health Division Chief Executive Officer Former
Hillenbrand, Inc. Interim President Former
Pharmacia Corporation President Former
Bayer HealthCare, Animal Health Division President Former
Hillenbrand Industries, Inc. President Former
Pharmacia Corporation Chief Operating Officer Former
Bayer Corporation Executive Vice President Former
Bayer Healthcare AG Chairman Former
Auxilium Pharmaceuticals, Inc. Director Former
Pharmanet Development Group, Inc. Board of Directors Former
University of Gothenburg Business Degree Former
Enzon Pharmaceuticals, Inc. member Former
Organization Position Status
Millipore Corporation Board of Directors Current
Organization Position Status
Ischemix Inc Vice President, Research Current
Brandeis University Visiting Professor of Chemistry Current
Millipore Corporation Director Current
The International Journal Member Former
Surface Logix, Inc. Senior Scientist Former
Solid Corporation Editor Former
Brandeis University Ph.D. In Synthetic Organic Chemistry Former
Bates College B.S. In Chemistry Former
Brandeis University Chemistry Former

Executive News

  • Martin Madaus Joins Mettler Toledo Board of Directors

    Financials.com - 6/22/09 - View Story

  • Martin Madaus Joins Mettler Toledo Board of Directors

    NewsBlaze - 6/22/09 - View Story

  • Mettler-Toledo Intl. Appoints Martin Madaus To Board - Quick Facts

    RTTNews.com - 6/22/09 - View Story

  • Martin Madaus Joins Mettler Toledo Board of Directors

    Stockwatch - 6/22/09 - View Story

  • Martin Madaus Joins Mettler Toledo Board of Directors

    Yahoo! Canada - 6/22/09 - View Story

  • Martin Madaus Joins Mettler Toledo Board of Directors

    PR Newswire via Yahoo! - 6/22/09 - View Story

  • Millipore Unveils Its First Single-Use Bioreactor For Process Development

    Pharma Live - 6/16/09 - View Story

  • Millipore Corp. Appoints New VP, Strategy and Corporate Development

    TradingMarkets - 6/15/09 - View Story

  • Millipore Opens New Bioprocess Manufacturing Facility in Massachusetts

    Industry Week - 6/15/09 - View Story

  • Millipore Unveils Its First Single-Use Bioreactor For Process Development

    DiGiTAL50 - 6/12/09 - View Story

  • Millipore Unveils Its First Single-Use Bioreactor For Process Development

    Reuters - 6/12/09 - View Story

  • Millipore Unveils Its First Single-Use Bioreactor For Process

    Business Wire via MSN Money - 6/12/09 - View Story

  • Millipore Unveils Its First Single-Use Bioreactor For Process Development

    Business Wire - 6/12/09 - View Story

  • Millipore Opens New Site in Massachusetts

    TradingMarkets - 6/12/09 - View Story

  • Millipore Corporation Announces Appointment of Strategy and Corporate Development Vice President

    Business Wire - 6/10/09 - View Story

  • Millipore Announces Go Mobius Tour

    Pharma Live - 6/09/09 - View Story

  • Millipore Officially Opened New Bioprocess Manufacturing Facility in Massachusetts

    Street Insider - 6/09/09 - View Story

  • UMass Lowell Graduates Record Number

    Reuters - 5/30/09 - View Story

  • UMass Lowell Graduates Record Number

    Forbes.com - 5/30/09 - View Story

  • UMass Lowell Graduates Record Number

    PR Newswire - 5/30/09 - View Story

advertisement
     MIL $27.42 -42.58 (-60.83% )
Average Volume 729,310
Shares Outstanding 55.43M
Market Cap 1.5B
Year High 76.92
Year Low 25
Earnings Per Share N/A
P/E Ratio -
Dividend N/A
Yield N/A
advertisement